June 2, 2026 June 2, 2026Categories News StoriesEA5142, an ALCHEMIST trial, adds to the knowledge base about optimal timing of adjuvant immunotherapy in non-small cell lung cancer
June 2, 2026 June 2, 2026Categories News StoriesWATCH: Dr. Jamie Chaft discusses the results of ALCHEMIST EA5142, a randomized phase 3 study of nivolumab after surgery and adjuvant chemotherapy in non-small cell lung cancer
June 1, 2026 June 1, 2026Categories News StoriesJAMA publishes ALCHEMIST EA5142 results: Nivolumab does not further reduce the risk of recurrence in patients with resected non-small cell lung cancer
May 28, 2026 May 28, 2026Categories Announcements News StoriesThe May 2026 News from ECOG-ACRIN blog is now available
May 15, 2026 May 15, 2026Categories Announcements News StoriesThe Spring 2026 advocacy blog Considering Clinical Trials is now available
April 27, 2026 April 27, 2026Categories Announcements News StoriesThe April 2026 News from ECOG-ACRIN blog is now available
April 8, 2026 April 8, 2026Categories News StoriesECOG-ACRIN vice chair Dr. Al Benson discusses the evolving role of first-line immunotherapy for advanced anal cancer, referencing the InterAACT-2 and EA2176 trials
April 8, 2026 April 8, 2026Categories News StoriesGroup co-chair Dr. Mitchell Schnall named a health system chief digital officer to know in 2026
March 30, 2026 March 30, 2026Categories Announcements News StoriesThe March 2026 News from ECOG-ACRIN blog is now available
